Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,060 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Tur C, Dubessy AL, Otero-Romero S, Amato MP, Derfuss T, Di Pauli F, Iacobaeus E, Mycko M, Abboud H, Achiron A, Bellinvia A, Boyko A, Casanova JL, Clifford D, Dobson R, Farez MF, Filippi M, Fitzgerald KC, Fonderico M, Gouider R, Hacohen Y, Hellwig K, Hemmer B, Kappos L, Ladeira F, Lebrun-Frénay C, Louapre C, Magyari M, Mehling M, Oreja-Guevara C, Pandit L, Papeix C, Piehl F, Portaccio E, Ruiz-Camps I, Selmaj K, Simpson-Yap S, Siva A, Sorensen PS, Sormani MP, Trojano M, Vaknin-Dembinsky A, Vukusic S, Weinshenker B, Wiendl H, Winkelmann A, Zuluaga Rodas MI, Tintoré M, Stankoff B. Tur C, et al. Among authors: casanova jl. Mult Scler. 2022 Aug;28(9):1424-1456. doi: 10.1177/13524585211069068. Epub 2022 Feb 23. Mult Scler. 2022. PMID: 35196927 Review.
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, Rouilly V, Saint-André V, Dott T, Pozo AR, Yatim N, Schwartz O, Cervantes-Gonzalez M, Ghosn J, Bastard P, Casanova JL, Szwebel TA, Terrier B, Conlon N, O'Farrelly C, Cheallaigh CN, Bourke NM, Duffy D. Smith N, et al. Among authors: casanova jl. Nat Commun. 2022 Nov 25;13(1):7254. doi: 10.1038/s41467-022-34895-1. Nat Commun. 2022. PMID: 36434007 Free PMC article.
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study.
Arrestier R, Bastard P, Belmondo T, Voiriot G, Urbina T, Luyt CE, Gervais A, Bizien L, Segaux L, Ben Ahmed M, Bellaïche R, Pham T, Ait-Hamou Z, Roux D, Clere-Jehl R, Azoulay E, Gaudry S, Mayaux J, Fage N, Ait-Oufella H, Moncomble E, Parfait M, Dorgham K, Gorochov G, Mekontso-Dessap A, Canoui-Poitrine F, Casanova JL, Hue S, de Prost N. Arrestier R, et al. Among authors: casanova jl. Ann Intensive Care. 2022 Dec 31;12(1):121. doi: 10.1186/s13613-022-01095-5. Ann Intensive Care. 2022. PMID: 36586050 Free PMC article.
Pre-Covid-19, SARS-CoV-2-Negative Multisystem Inflammatory Syndrome in Children.
Benezech S, Khoryati L, Cognard J, Netea SA, Khan T, Moreews M, Saker K, De Guillebon JM, Khaldi-Plassart S, Pescarmona R, Viel S, Malcus C, Perret M, Ar Gouilh M, Vabret A, Venet F, Remy S, Chopin E, Lina G, Vandenesch F, Rousseaux N, Bastard P, Zhang SY, Casanova JL, Trouillet-Assant S, Walzer T, Kuijpers TW, Javouhey E, Dauwalder O, Marr N, Belot A. Benezech S, et al. Among authors: casanova jl. N Engl J Med. 2023 Nov 30;389(22):2105-2107. doi: 10.1056/NEJMc2307574. N Engl J Med. 2023. PMID: 38048195 Free PMC article. No abstract available.
Reconciling Mouse and Human Immunology at the Altar of Genetics.
Gros P, Casanova JL. Gros P, et al. Among authors: casanova jl. Annu Rev Immunol. 2023 Apr 26;41:39-71. doi: 10.1146/annurev-immunol-101721-065201. Epub 2022 Dec 16. Annu Rev Immunol. 2023. PMID: 36525691 Free article. Review.
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study.
Cognasse F, Hamzeh-Cognasse H, Rosa M, Corseaux D, Bonneaudeau B, Pierre C, Huet J, Arthaud CA, Eyraud MA, Prier A, Duchez AC, Ebermeyer T, Heestermans M, Audoux-Caire E, Philippot Q, Le Voyer T, Hequet O, Fillet AM, Chavarin P, Legrand D, Richard P, Pirenne F, Gallian P, Casanova JL, Susen S, Morel P, Lacombe K, Bastard P, Tiberghien P. Cognasse F, et al. Among authors: casanova jl. EBioMedicine. 2023 Jan;87:104414. doi: 10.1016/j.ebiom.2022.104414. Epub 2022 Dec 17. EBioMedicine. 2023. PMID: 36535107 Free PMC article.
Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq.
Vazquez SE, Mann SA, Bodansky A, Kung AF, Quandt Z, Ferré EMN, Landegren N, Eriksson D, Bastard P, Zhang SY, Liu J, Mitchell A, Proekt I, Yu D, Mandel-Brehm C, Wang CY, Miao B, Sowa G, Zorn K, Chan AY, Tagi VM, Shimizu C, Tremoulet A, Lynch K, Wilson MR, Kämpe O, Dobbs K, Delmonte OM, Bacchetta R, Notarangelo LD, Burns JC, Casanova JL, Lionakis MS, Torgerson TR, Anderson MS, DeRisi JL. Vazquez SE, et al. Among authors: casanova jl. Elife. 2022 Oct 27;11:e78550. doi: 10.7554/eLife.78550. Elife. 2022. PMID: 36300623 Free PMC article.
Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy.
Zhang Y, Vandestienne M, Lavillegrand JR, Joffre J, Santos-Zas I, Lavelle A, Zhong X, Le Goff W, Guérin M, Al-Rifai R, Laurans L, Bruneval P, Guérin C, Diedisheim M, Migaud M, Puel A, Lanternier F, Casanova JL, Cochain C, Zernecke A, Saliba AE, Mokry M, Silvestre JS, Tedgui A, Mallat Z, Taleb S, Lenoir O, Vindis C, Camus SM, Sokol H, Ait-Oufella H. Zhang Y, et al. Among authors: casanova jl. Nat Commun. 2023 Aug 1;14(1):4622. doi: 10.1038/s41467-023-40216-x. Nat Commun. 2023. PMID: 37528097 Free PMC article.
1,060 results